Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats

Brain Research

Volumn 765, Issue 1, 1997, Pages 149-158

  Yan, Qing Shan ^a   Reith, Maarten E A ^a   Jobe, Phillip C ^a   Dailey, John W ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Dopamine; Microdialysis; MK 801 (dizocilpine); Norepinephrine; Nucleus accumbens; Serotonin

Indexed keywords

DIZOCILPINE;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINE BRAIN LEVEL; DRUG EFFECT; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ANIMALS; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NOREPINEPHRINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SYNAPTIC TRANSMISSION; TETRODOTOXIN;

EID: 0007735724     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00568-4     Document Type: Article

References (70)

1. Araki M., McGeer P.L., McGeer E.G. Striatonigral and pallidonigral pathways studies by a combination of retrograde horseradish peroxidase tracing and a pharmacohistochemical method for α-aminobutyric acid transaminase. Brain Res. 331:1985;17-24.
2. Bean A.J., Roth R.H. Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J. Neurosci. 11:1991;2694-2702.
3. Becquet D., Faudon M., Hery F. In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons. Brain Res. 519:1990;82-88.
4. Bubser M., Keseberg U., Notz P.K., Schmidt W.J. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur. J. Pharmacol. 229:1992;75-82.
5. Carboni E., Di Chiara G. Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience. 32:1989;637-645.
6. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28:1989;653-661.
7. Carlsson M., Carlsson A. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural Transm. 75:1989;221-226.
8. Carlsson M., Carlsson A. Interaction between glutamatergic and monoaminergic systems within the basal ganglia-implication for schizophrenia and Parkinson's disease. Trends Neurosci. 13:1990;272-276.
9. 3H]GABA. Neuroscience. 22:1987;425-439.
10. Criswell H.E., Johnson K.B., Mueller R.A., Breese G.R. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J. Pharmacol. Exp. Ther. 265:1993;1001-1010.
11. Dai H., Gebhardt K., Carey R.J. Time course effects of MK-801: the relationship between brain neurochemistry and behavior. Brain Res. Bull. 36:1995;175-180.
12. Finnegan K.T., Taraska T. Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo. J. Neurochem. 66:1996;1949-1958.
13. French E.D., Mura A., Wang T. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. Synapse. 13:1993;108-116.
14. Fuller T.A., Russchen F.T., Price J.L. Source of presumptive glutamatergic aspartatergic afferents to the rats ventral striatopallidal region. J. Comp. Neurol. 258:1987;317-338.
15. 3H-catecholamines by rat striatal and hypothalamic synaptosomes. Life Sci. 18:1976;1105-1110.
16. Giorguieff M.F., Kemel M.L., Glowinski J. Presynaptic effect of L-glutamic acid on the release of dopamime in rat striatal slices. Neurosci. Lett. 6:1977;73-77.
17. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
18. Hadjiconstantinou M., Rossetti Z.L., Wemlinger T.A., Neff N.H. Dizocilpine enhances striatal tyrosine hydroxylase and aromatic L-amino acid decarboxylase activity. Eur. J. Pharmacol. 289:1995;97-101.
19. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
20. Hondo H., Yonezawa Y., Nakahara T., Nakamura K., Hirano M., Uchimura H., Tashiro N. Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res. 633:1994;337-342.
21. Imperato A., Honore T., Jensen L.H. Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats. Brain Res. 530:1990;223-228.
22. Imperato A., Scrocco M.G., Bacchi S., Angelucci L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187:1990;555-556.
23. Jedema H.P., Moghaddam B. Characterization of excitatory amino acid modulation of dopamine release in the prefrontal cortex of conscious rats. J. Neurochem. 66:1996;1448-1453.
24. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18:1993;75-113.
25. Kashiwa A., Nishikawa T., Nishijima K., Umino A., Takahashi K. Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex. Neurochem. Int. 26:1995;269-279.
26. Kashihara K., Hamamura T., Okumura K., Otsuki S. Effect of MK-801 on endogenous dopamine release in vivo. Brain Res. 528:1990;80-82.
27. Kelley A.E., Domesick V.B. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience. 7:1982;2321-2335.
28. Kelley A.E., Domesick V.B., Nauta W.J.H. The amygdalostriatal projection in the rat: an anatomical study by anterograde and retrograde tracing methods. Neuroscience. 7:1982;615-630.
29. Kemp J.A., Foster A.C., Wong E.H.F. Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci. 10:1987;294-298.
30. Koek W., Woods J.H., Winger G.D. MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245:1988;969-974.
31. Lategan A.J., Marien M.R., Colpaert F.C. Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Res. 523:1990;134-138.
32. Lategan A.J., Marien M.R., Colpaert F.C. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci. 50:1992;995-999.
33. Leviel V., Gobert A., Guibert B. The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience. 39:1990;305-312.
34. Liljequist S., Ossowska K., Grabowska-Anden M., Anden N.E. Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur. J. Pharmacol. 195:1991;55-61.
35. Löscher W., Annies R., Honack D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128:1991;191-194.
36. Löscher W., Hönack D. The behavioral effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur. J. Pharmacol. 215:1992;199-208.
37. 1A receptor antagonist, (+)-WAY 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats. Eur. J. Pharmacol. 242:1993;99-104.
38. Mathe J.M., Nomikos G.G., Hildebrand B.E., Hertel P., Svensson T.H. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 309:1996;1-11.
39. Martin P., Svensson A., Carlsson A., Carlsson M.L. On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801. J. Neural Transm. 95:1994;113-121.
40. Maurice T., Vignon J., Kamenka J.-M., Chicheportiche R. Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo. J. Neurochem. 56:1991;553-559.
41. McCullough L.D., Salamone J.D. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine in the nucleus accumbens. Brain Res. 577:1992;1-9.
42. Morari M., O'Connor W.T., Ungerstedt U., Bianchi C., Fuxe K. Functional neuroanatomy of the nigrostriatal and striatonigral pathway as studies with dual probe microdialysis in the awake rat. II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function Neuroscience. 72:1996;89-97.
43. Murase S., Mathe J.M., Grenhoff J., Svensson T.H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J. Neural Transm. Gen. Sect. 91:1993;13-25.
44. Nishijima K., Kashiwa A., Nishikawa T. Preferential stimulation of extracellular release of dopamine in rat frontal cortex to striatum following competitive inhibition of the N-methyl-D-aspartate receptor. J. Neurochem. 63:1994;375-378.
45. Ogren S.O., Goldstein M. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology. 11:1994;167-177.
46. Ouagazzal A., Nieoullon A., Amalric M. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology. 111:1993;427-434.
47. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York, 1986.
48. Roberts P.J., Sharif N.A. Effects of L-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices. Brain Res. 157:1978;391-395.
49. Sommermeyer H., Frielingsdorf J., Knorr A. Effects of prazosin on the dopaminergic neurotransmission in rat brain. Eur. J. Pharmacol. 276:1995;267-270.
50. Steinpreis R.E., Salamone J.D. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res. 612:1993;263-270.
51. B receptors originate from discrete afferent neurons. Neurosci. Lett. 134:1992;207-211.
52. 1-adrenoceptor antagonism. J. Clin. Psychopharmacol. 15(Suppl.):1995;11S-18S.
53. Tiedtke P.I., Bischoff C., Schmidt W.J. MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J. Neural Transm. 81:1990;173-182.
54. Van Den Pol A.N., Smith A.D., Powell J.F. GABA axons in synaptic contact with dopamine neurons in the substantia nigra: double immunocytochemistry with biotin-peroxidase and protein A-colloidal gold. Brain Res. 348:1985;146-154.
55. Walaas I., Fonnum F. The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat. Neuroscience. 4:1979;209-216.
56. Walaas I., Fonnum F. Biochemical evidence of γ-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat. Neuroscience. 5:1980;63-72.
57. Wedzony K., Klimek V., Golembiowska K. MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res. 622:1993;325-329.
58. Weihmuller F.B., O'Dell S.J., Cole B.N., Marshall J.F. Mk-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study. Brain Res. 549:1991;230-235.
59. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo. J. Neurochem. 58:1992;1573-1575.
60. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci. Lett. 142:1992;5-8.
61. Willins D.L., Narayanan S., Wallace L.J., Uretsky N.J. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801. Pharmacol. Biochem. Behav. 46:1993;881-887.
62. Wolf M.E., White F.J., Hu X.-T. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behav. Pharmacol. 4:1993;429-442.
63. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.
64. Wong E.H.F., Knight A.R., Woodruff G.N. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 50:1988;274-281.
65. Yan Q.S., Mishra P.K., Burger R.L., Bettendorf A.F., Jobe P.C., Dailey J.W. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J. Pharmacol. Exp. Ther. 261:1992;652-659.
66. Young A.M.J., Bradford H.F. N-methyl-D-aspartate releases γ-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method. J. Neurochem. 60:1993;487-492.
67. Zahm D.S. The ventral striatopallidal parts of the basal ganglia in the rat. II. Compartmentation of ventral pallidal efferents Neuroscience. 30:1989;33-50.
68. Zhang J., Chiodo L.A., Freeman A.S. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res. 590:1992;153-163.
69. Zhang J., Chiodo L.A., Freeman A.S. Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons. Eur. J. Pharmacol. 230:1993;371-374.
70. Zetterström T., Sharp T., Collin A.K., Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs: implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:1988;327-334.